Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancer

F. Rojo, J. García-Parra, S. Zazo, I. Tusquets, J. Ferrer-Lozano, S. Menendez, P. Eroles, C. Chamizo, S. Servitja, N. Ramírez-Merino, F. Lobo, B. Bellosillo, J. M. Corominas, J. Yelamos, S. Serrano, A. Lluch, A. Rovira, J. Albanell

Research output: Contribution to journalArticleResearchpeer-review

136 Citations (Scopus)


Background: Poly(ADP-ribose)polymerase-1 (PARP-1) is a highly promising novel target in breast cancer. However, the expression of PARP-1 protein in breast cancer and its associations with outcome are yet poorly characterized. Patients and methods: Quantitative expression of PARP-1 protein was assayed by a specific immunohistochemical signal intensity scanning assay in a range of normal to malignant breast lesions, including a series of patients (N = 330) with operable breast cancer to correlate with clinicopathological factors and long-term outcome. Results: PARP-1 was overexpressed in about a third of ductal carcinoma in situ and infiltrating breast carcinomas. PARP-1 protein overexpression was associated to higher tumor grade (P = 0.01), estrogen-negative tumors (P < 0.001) and triple-negative phenotype (P < 0.001). The hazard ratio (HR) for death in patients with PARP-1 overexpressing tumors was 7.24 (95% CI; 3.56-14.75). In a multivariate analysis, PARP-1 overexpression was an independent prognostic factor for both disease-free (HR 10.05; 95% CI 5.42-10.66) and overall survival (HR 1.82; 95% CI 1.32-2.52). Conclusions: Nuclear PARP-1 is overexpressed during the malignant transformation of the breast, particularly in triple-negative tumors, and independently predicts poor prognosis in operable invasive breast cancer. © The Author 2011. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved.
Original languageEnglish
Pages (from-to)1156-1164
JournalAnnals of Oncology
Issue number5
Publication statusPublished - 1 May 2012


  • Biomarker
  • Breast cancer
  • PARP-1
  • Prognosis
  • Triple negative


Dive into the research topics of 'Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancer'. Together they form a unique fingerprint.

Cite this